Relative Bioavailability of CE-Iohexol (Captisol-enabled ™ Iohexol) Injection and Omnipaque™ Injection
Conditions: Contrast-induced Nephropathy; Coronary Angiography Interventions: Other: Omnipaque™ (iohexol) Injection; Other: CE-Iohexol Sponsors: CyDex Pharmaceuticals, Inc.; Ligand Pharmaceuticals; Syneos Health Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials